Howard Marks’s Core Scientific CORZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$128M Sell
4,993,708
-4,357,000
-47% -$103M 1.77% 11
2026
Q1
$140M Buy
9,350,708
+1,000,000
+12% +$17.1M 2.13% 10
2025
Q4
$122M Buy
8,350,708
+1,950,000
+30% +$34M 1.73% 12
2025
Q3
$115M Buy
+6,400,708
New +$93.9M 1.77% 11

Other funds holding CORZ

Howard Marks's CORZ Position: Q2 2026 in Review

Howard Marks reduced its Core Scientific (CORZ) stake by 47% in Q2 2026, selling an estimated $103M and leaving 4,993,708 shares worth $128M. The position accounts for 1.77% of the portfolio, ranked #11.

Howard Marks first reported a position in CORZ in Q3 2025 and has held it in 4 quarters since. The position peaked at $140M in Q1 2026. 411 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Howard Marks held 4,993,708 shares of Core Scientific worth $128M as of Q2 2026.
  • Howard Marks sold 4,357,000 Core Scientific shares in Q2 2026, an estimated $103M.
  • Core Scientific made up 1.77% of Howard Marks's portfolio in Q2 2026, its #11 holding.
  • Howard Marks first reported a position in Core Scientific in Q3 2025 and has held it in 4 quarters since.
  • Howard Marks's Core Scientific position peaked at $140M in Q1 2026.
  • 411 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Oaktree Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.